C-PJFVNeuroNascent Inc (NNI)
oral small molecules, neurogenesis, neuron regeneration
replacementreplacingsmall molecule
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-PJFV
C-PJFVC-PJFVoral small molecules, neurogenesis, neuron regeneration
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Neuronascent states that it is developing therapies for Alzheimer's disease, stroke, and depression grounded in the science of neurogenesis, with the belief that effective treatment should reduce neuron loss, restore and replace damaged neurons, promote the formation of new neurons, and reverse cognitive loss.
SourceNeuronascent states that it discovers and develops small-molecule therapies for depression, Down syndrome, post-traumatic stress disorder, Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders. The company says its lead candidates promote the formation of new neurons from the brain's own neural stem and progenitor cell populations, have shown promise in cell culture and disease models without signs of toxicity, and are uniquely optimized for each indication to increase neuron numbers, improve critical function, and reduce neuron loss as disease progresses.
SourceNeuronascent states that therapies grounded in the science of neurogenesis can address Alzheimer's disease, depression, and stroke by reducing neuron loss, restoring and replacing damaged neurons, promoting the formation of new neurons, and reversing cognitive loss.
SourceNeuronascent states that it discovers and develops therapies for depression, Alzheimer's, Parkinson's, and other neurodegenerative diseases based on the science of neurogenesis, with the goal of reducing neuron loss, restoring and replacing damaged neurons, promoting the formation of new neurons, and reversing cognitive loss.
SourceNeuroNascent states that it is focused on discovering and developing therapies for Alzheimer's disease, stroke, and depression based on the science of neurogenesis, with the aims of reducing neuron loss, restoring and replacing damaged neurons, promoting the formation of new neurons, and reversing cognitive loss.
SourceNo company beliefs, mission, or longevity-related theories are stated in the visible text of this Wayback snapshot; it appears to be only a directory index page for neuronascent.com.
SourceNo company beliefs, mission, or theory statements are visible in this snapshot. The archived page is an Apache directory index for www.neuronascent.com showing folders and files, plus Wayback metadata.
Source